Development of Physical Activity Features for Ear-worn Devices
NCT ID: NCT05350046
Last Updated: 2023-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2022-07-11
2023-04-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physically active adults
A cohort of physically-active adults will use ear-worn prototype devices and established gold standard and comparator devices during rest periods, physical activity, and various activities of daily living.
Ear-worn prototype devices
Hearing instrument including sensors to track movement and estimations of biological information.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ear-worn prototype devices
Hearing instrument including sensors to track movement and estimations of biological information.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimum height 5'3"
* Fully vaccinated against Covid -19
* Willing and able perform various exercise activities at a light and moderate relative intensity, such as riding a stationary bike, walking and jogging on a treadmill, and performing squatting movements.
* Non-smoker for the past 6 months.
* Willing to abstain from caffeine and alcohol 6 hours before participation.
* Willing to fast from eating 4 hours before participation.
Exclusion Criteria
* Diagnosed with diabetes mellitus or other metabolic disorder.
* History of cerebral vascular accident.
* History of pulmonary disorder.
* Experiencing orthopedic injury or disorders that restrict movement or cause painful physical activity.
* History of neurodegenerative or neuromuscular pathology.
* Advised by a healthcare professional to not participate in physical activity.
40 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philips BioTelemetry Research
UNKNOWN
Trialfacts
UNKNOWN
57GGardner
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
57GGardner
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher Ross, MS
Role: STUDY_DIRECTOR
Sonova USA Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sonova Silicon Valley
Fremont, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SRF-485
Identifier Type: -
Identifier Source: org_study_id